Abstracts Archive - Page 138 of 1683 - ATC Abstracts

2022 American Transplant Congress
Incidence of Urinary Tract Infection or Asymptomatic Bacteriuria in Kidney Transplant Recipients with Sulfamethoxazole-Trimethoprim vs. Pentamidine for Pneumocystis Jiroveci Pneumonia Prophylaxis
L. Selznick, H. Sweiss, C. Long, S. Bhayana, R. Hall
University Health, San Antonio, TX
*Purpose: To compare the incidence of urinary tract infection (UTI) or asymptomatic bacteriuria (ASB) post-kidney transplant (KT) with multiple Pneumocystis jiroveci pneumonia (PJP) prophylaxis regimens*Methods:…
2022 American Transplant Congress
Telemedicine Implementation in Solid Organ Transplant (SOT) Clinics is Associated with Satisfaction Among Patients and Providers but Increased Burden on Staff
C. W. Wang, N. Ha, M. Duarte, C. B. Sherman
University of California, San Francisco, San Francisco, CA
*Purpose: Telemedicine is an essential part of healthcare delivery and has grown exponentially during the COVID-19 pandemic. Data on optimal utilization and implementation of telemedicine…
2022 American Transplant Congress
Outcomes of Sensitized Simultaneous Liver-Kidney Transplant
E. R. Kitchel, T. Tan, A. Wadhwa, D. G. Farmer, S. Bunnapradist
David Geffen School of Medicine, Los Angeles, CA
*Purpose: Pre-formed donor-specific HLA antibodies (DSAs) in simultaneous liver-kidney transplants (SLKTs) have been associated with increased risk of antibody mediated rejection (AMR) and negative transplant…
2022 American Transplant Congress
Optimizing Multimodal Pain Control Post Laparoscopic Living Donor Nephrectomy
J. Francois Whitt¹, A. Centeno¹, T. Harrison¹, P. Cabrera¹, S. Zahid¹, L. Chen²
¹Jackson Memorial Hospital, Miami, FL, ²University of Miami/Jackson Memorial Hospital, Miami, FL
*Purpose: The purpose of this study is to examine the use of a multimodal pain regimen in our diverse population to better characterize short and…
2022 American Transplant Congress
Nivolumab After Sorafenib Failure in Liver Recipients with HCC Recurrence
J. Kwon
Surgery, Samsung Medical Center, Seoul, Korea, Republic of
*Purpose: Several treatments have recently been known for hepatocellcular carcinoma (HCC) who have failed to treat sorafenib. Immune checkpoint inhibitors have proven to be effective,…
2022 American Transplant Congress
Are Changes in Clinical Practice Reflected in Gene Expression Profiling Scores After Heart Transplantation?
T. Wolf-Doty¹, K. K. Khush², J. J. Teuteberg²
¹CareDx, Brisbane, CA, ²Stanford University, Stanford, CA
*Purpose: AlloMap (AM) is a peripheral blood gene expression profiling (GEP) tool used for the assessment of acute cellular rejection in heart transplant recipients (HT).…
2022 American Transplant Congress
Establishment of an In Vitro Assay to Evaluate Indirect T-cell Allo-Response Using Donor PBMC-Pulsed Dendritic Cells
K. Iwasaki¹, T. Tomosugi², T. Sekiya³, H. Hamana⁴, Y. Miwa¹, K. Futamura², M. Okada², T. Hiramitsu², N. Goto², S. Narumi², Y. Watarai², H. Kishi⁴, M. Okumura⁵, S. Ashimine⁵, K. Ishiyama⁵, T. Kobayashi⁵
¹Department of Kidney Diseases and Transplant Immunology, Aichi Medical University School of Medicine, Nagakute, Japan, ²Department of Transplant Surgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan, ³Department of Immune Regulation, The Research Center for Hepatitis and Immunology, Ichikawa, Japan, ⁴Department of Immunology, University of Toyama, Toyama, Japan, ⁵Department of Renal Transplant Surgery, Aichi Medical University School of Medicine, Nagakute, Japan
*Purpose: Conventional MLR-based methods which evaluate donor-specific immune response via direct T-cell recognition pathway have been reported to be useful in predicting acute TCMR. However,…
2022 American Transplant Congress
Molecular ABO Typing: An Effective Tool for Resolving Deceased Donor Indeterminate ABO Types
D. Tanglao¹, S. S. Musa¹, J. J. Chew¹, L. Santiago², K. Herron³, B. O'Neale³, N. A. Lemp¹, S. O. Dionne⁴
¹Eurofins DPT, Los Angeles, CA, ²Eurofins DPT, Centennial, CO, ³Eurofins DPT, Centennial, CA, ⁴Eurofins DPT, denver, CO
*Purpose: In order to evaluate molecular ABO typing as an alternative method of blood typing that may be employed when indeterminate serological typing results are…
2022 American Transplant Congress
A Intention-to-Treat Analysis of 881 Consecutively Waitlisted Patients to Develop a Survival Benefit Model for Hepatocellular Carcinoma Liver Transplant Candidates
B. V. Tran¹, W. Lapisatepun¹, W. Dumronggittigule¹, D. Markovic², Y. Lee¹, F. Kaldas¹, D. Farmer¹, R. Busuttil¹, V. Agopian¹
¹Department of Surgery, University of California Los Angeles, Los Angeles, CA, ²Department of Medicine, Statistics Core, University of California Los Angeles, Los Angeles, CA
*Purpose: The current liver transplantation (LT) selection paradigm for hepatocellular carcinoma (HCC) patients ignores the variable risks of waitlist dropout and post-LT recurrence/death, with the…
2022 American Transplant Congress
A Dose Dependent Effect of Varying Tacrolimus Concentrations on Cytomegalovirus Viral Specific T Cell Interferon Gamma Expression
H. L. Kleiboeker¹, M. R. Jorgenson¹, R. O. Meyers², O. Ganz², S. Parajuli³, J. Galipeau⁴
¹Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI, ²Program for Advanced Cell Therapy, University of Wisconsin Hospital and Clinics and School of Medicine and Public Health, Madison, WI, ³Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Medicine, Division of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Tacrolimus, considered the backbone of transplant immunosuppression, is associated with increased risk of viral infections, including cytomegalovirus (CMV), due to its potent inhibitory effect…